J Immunother. 2005 Nov-Dec;28(6):593-8.

Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer.

Blansfield JA, Beck KE, Tran K, Yang JC, Hughes MS, Kammula US, Royal RE, Topalian SL, Haworth LR, Levy C, Rosenberg SA, Sherry RM.

Source

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1201, USA.

Abstract

Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) is an immunoregulatory molecule expressed by activated T cells and resting CD4CD25 T cells. In patients with advanced melanoma, our group reported that administration of anti-CTLA-4 antibody mediated objective cancer regression in 13% of patients. This study also established that the blockade of CTLA-4 was associated with grade III/IV autoimmune manifestations that included dermatitis, enterocolitis, hepatitis, uveitis, and a single case of hypophysitis. Since this initial report, 7 additional patients with anti-CTLA-4 antibody-induced autoimmune hypophysitis have been accumulated. The characteristics, clinical course, laboratory values, radiographic findings, and treatment of these 8 patients are the focus of this report.

PMID:: 16224277; [PubMed - indexed for MEDLINE]
PMCID:: PMC2154350

Free PMC Article

Images from this publication.See all images (1) Free text

Publication Types, MeSH Terms, Substances, Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Autoimmune Diseases - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patient. [Melanoma Res. 2009]
Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patient.
Kaehler KC, Egberts F, Lorigan P, Hauschild A. Melanoma Res. 2009 Oct; 19(5):333-4.
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. [Proc Natl Acad Sci U S A. 2003]
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.
Phan GQ, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Restifo NP, Haworth LR, Seipp CA, Freezer LJ, et al. Proc Natl Acad Sci U S A. 2003 Jul 8; 100(14):8372-7. Epub 2003 Jun 25.
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. [J Clin Oncol. 2006]
Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4.
Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D, et al. J Clin Oncol. 2006 May 20; 24(15):2283-9.
Review CTLA-4 blockade with monoclonal antibodies in patients with metastatic cancer: surgical issues. [Ann Surg Oncol. 2008]
Review CTLA-4 blockade with monoclonal antibodies in patients with metastatic cancer: surgical issues.
Phan GQ, Weber JS, Sondak VK. Ann Surg Oncol. 2008 Nov; 15(11):3014-21. Epub 2008 Aug 21.
Review Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes. [Pituitary. 2010]
Review Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes.
Dillard T, Yedinak CG, Alumkal J, Fleseriu M. Pituitary. 2010; 13(1):29-38. Epub 2009 Jul 29.

See reviews... See all...

Cited by 23 PubMed Central articles

A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma. [PLoS One. 2012]
A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma.
Sampson JH, Schmittling RJ, Archer GE, Congdon KL, Nair SK, Reap EA, Desjardins A, Friedman AH, Friedman HS, Herndon JE 2nd, et al. PLoS One. 2012; 7(2):e31046. Epub 2012 Feb 27.
Novel treatments for metastatic cutaneous melanoma and the management of emergent toxicities. [Clin Med Insights Oncol. 2012]
Novel treatments for metastatic cutaneous melanoma and the management of emergent toxicities.
Lemech C, Arkenau HT. Clin Med Insights Oncol. 2012; 6:53-66. Epub 2012 Jan 5.
Review Tumor evasion from T cell surveillance. [J Biomed Biotechnol. 2011]
Review Tumor evasion from T cell surveillance.
Töpfer K, Kempe S, Müller N, Schmitz M, Bachmann M, Cartellieri M, Schackert G, Temme A. J Biomed Biotechnol. 2011; 2011:918471. Epub 2011 Nov 15.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypop...
Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer.
J Immunother. 2005 Nov-Dec ;28(6):593-8.

PubMed
Relationship between interleukin-6 levels and platelet counts in systemic juveni...
Relationship between interleukin-6 levels and platelet counts in systemic juvenile rheumatoid arthritis: comment on the article by De Benedetti et al.
Arthritis Rheum. 1992 Jul ;35(7):840.

PubMed
Palliative care in patients with brain metastases.
Palliative care in patients with brain metastases.
Curr Opin Oncol. 2005 Nov ;17(6):588-92.

PubMed
Antiangiogenic drugs for chemotherapy of bladder tumours.
Antiangiogenic drugs for chemotherapy of bladder tumours.
Chemotherapy. 2005 Oct ;51(6):291-9. Epub 2005 Oct 13 .

PubMed
Early noninvasive ventilation averts extubation failure in patients at risk: a r...
Early noninvasive ventilation averts extubation failure in patients at risk: a randomized trial.
Am J Respir Crit Care Med. 2006 Jan 15 ;173(2):164-70. Epub 2005 Oct 13 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 23 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information